
Van Bael
Articles
-
Dec 17, 2024 |
concurrences.com | Van Bael |Van Hove |Jean-François Bellis |Valérie Lefever
On 18 December 2024, the Belgian Competition Authority (BCA) published what it calls a “short guide for tech challengers” (the Guide) which discusses the Digital Markets Act (DMA) and the benefits which the DMA is intended to bring to the digital sector in terms of innovation and competition by reducing entry and expansion barriers and improving fairness in the dealings of third parties with specific gatekeepers, the largest digital platforms in Europe (see, English version attached). These w...
-
Oct 30, 2024 |
concurrences.com | Van Bael |Michael Clancy |Peter L'Ecluse |Catherine Longeval
European Commission Imposes Heavy Fine on Teva for Misuse of Patent System and Disparaging Rival’s Product*Today, the European Commission (the Commission) fined Teva EUR 462.6 million for abusing its dominant position to delay the market entry of rival medicines for the treatment of relapsing forms of multiple sclerosis (see, attached press release and statement). The Commission established that Teva artificially delayed competition and extended the patent protection of its product Copaxone®...
-
Oct 30, 2024 |
concurrences.com | Van Bael |Michael Clancy |Peter L'Ecluse |Catherine Longeval
European Commission Imposes Heavy Fine on Teva for Misuse of Patent System and Disparaging Rival’s Product*Today, the European Commission (the Commission) fined Teva EUR 462.6 million for abusing its dominant position to delay the market entry of rival medicines for the treatment of relapsing forms of multiple sclerosis (see, attached press release and statement). The Commission established that Teva artificially delayed competition and extended the patent protection of its product Copaxone®...
-
Oct 9, 2024 |
concurrences.com | Van Bael |Michael Clancy |Peter L'Ecluse |Catherine Longeval
Previous article Next article Share on | The Swiss Competition Authority ( Competition Commission or Comco ) indicated today that it terminated its inquiry into patent litigation conducted by Novartis to protect Cosentyx®, a human IgG1 monoclonal antibody indicated for the treatment of several autoimmune diseases, including specific dermatological conditions (see, attached press release in four language versions). Both Comco and the European Commission (the Commission ) had sought to learn...
-
Oct 3, 2024 |
concurrences.com | Van Bael |Steve Ross |Richard Burton |Jeffrey Tassey
On 4 October 2024, the Spanish Competition Authority (“SCA”) adopted a decision imposing a € 2.43 million fine on the General Council of Court Attorneys (“CGPE”) for two unlawful practices which were found to infringe Article 101 TFEU and its national equivalent. The CGPE is a public association that represents all Spanish court attorneys at national level. It operates an online auction platform, which regional councils use in extra-judicial auctions (Spanish law provides for extrajudicial au...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →